Changing dialyser market leads to Gambro plant closures
This article was originally published in Clinica
Gambro has announced it is to close two manufacturing plants employing a total of around 220 people. The factories, in Dransfeld, Germany, and Koga, Japan, make non-synthetic dialysers. It will also terminate a non-synthetic manufacturing joint venture with Baxter in the US by the end of 2004.
You may also be interested in...
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.